Saturday, September 12, 2020

Astra Zeneca Definitely Expedited The Covid Vaccine Review Process As Trials Resume

It was clearly stated the goal was to expedite the process

“We are working to expedite (make (an action or process) happen sooner or be accomplished more quickly) the review of the single event to minimize any potential impact on the trial timeline," the company statement said.”
Mission Accomplished. Astra Zeneca Resumes Covid Trials

British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.

The late-stage trials of the experimental vaccine, one of the most advanced in development, were suspended this week after an illness in a study subject in Britain.

"The standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators," AstraZeneca said.

"The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume."

The company said it could not disclose further medical information.

"All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards."

No word on the status of the seriously sickened patient-
Swept under the rug. As expected.  The data will be cherry picked to exclude this severe reaction and all others...

No comments:

Post a Comment